advanced gastric adenocarcinoma
Showing 1 - 17 of 17
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Advanced Gastric Adenocarcinoma Trial in Henan (camrelizumab)
Recruiting
- Advanced Gastric Adenocarcinoma
-
Henan, ChinaHenan Tumor Hospital
Oct 13, 2022
Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSamsung Medical center
Jun 13, 2022
Advanced Gastric Adenocarcinoma Trial in Ho-nan (Camrelizumab, Albumin-bound paclitaxel, S-1)
Recruiting
- Advanced Gastric Adenocarcinoma
- Camrelizumab, Albumin-bound paclitaxel, S-1
-
Ho-nan, Henan, ChinaHenan Tumor Hospital
Apr 14, 2022
Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8
Recruiting
- Advanced Gastric Adenocarcinoma
- +32 more
- Lenvatinib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Mar 2, 2022
Advanced Gastric Adenocarcinoma Trial in Baltimore (Paclitaxel, Olaparib, Pembrolizumab)
Recruiting
- Advanced Gastric Adenocarcinoma
- Paclitaxel
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 3, 2022
Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid
Recruiting
- Advanced Gastric Adenocarcinoma
- Immunotherapy
- EV-array
-
Beijing, ChinaPeking University Cancer Hospital & Institute
Aug 5, 2021
Advanced Gastric Adenocarcinoma Trial in Xuzhou (LY011)
Recruiting
- Advanced Gastric Adenocarcinoma
- LY011
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Jul 23, 2021
Advanced Gastric Adenocarcinoma Trial in Seoul (GSK2636771, Paclitaxel)
Completed
- Advanced Gastric Adenocarcinoma
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System, Yonsei Canc
Apr 21, 2021
Advanced Gastric Adenocarcinoma Trial in Fuzhou (Camrelizumab, Apatinib Mesylate, POF)
Unknown status
- Advanced Gastric Adenocarcinoma
- Camrelizumab
- +2 more
-
Fuzhou, ChinaRongbo Lin
Nov 21, 2019
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD5363, paclitaxel, AZD2014)
Terminated
- Advanced Gastric Adenocarcinoma
- AZD5363
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical center
May 17, 2019
Advanced Gastric Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Shanghai (CAR-CLD18 T Cells)
Unknown status
- Advanced Gastric Adenocarcinoma
- Pancreatic Adenocarcinoma
- CAR-CLD18 T Cells
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 8, 2018
Advanced Gastric Adenocarcinoma Trial in Guangzhou (D2 lymphadenectomy, Systemic chemo, HIPEC)
Unknown status
- Advanced Gastric Adenocarcinoma
- D2 lymphadenectomy
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Abdominal Surgery (Section 2), Affiliated Tumor Ho
Sep 12, 2014